An evaluation of regulatory and commercial barriers to stratified medicine development and adoption
{{output}}
Today, a range of products based on genomics, proteomics and metabolomics have facilitated the development of 'stratified' medicines and companion diagnostics. This investigation profiles a series of targeted medicines and corresponding diagnostics, and their ... ...